Ikewaki Katsunori, Matsunaga Akira, Han Hua, Watanabe Hisayuki, Endo Akira, Tohyama Jun-ichiro, Kuno Mamoru, Mogi Jun-ichi, Sugimoto Ken-ichi, Tada Norio, Sasaki Jun, Mochizuki Seibu
Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan.
Atherosclerosis. 2004 Jan;172(1):39-45. doi: 10.1016/j.atherosclerosis.2003.09.024.
Familial HDL deficiency (FHD) is a rare autosomal dominant lipoprotein disorder. We describe a novel genetic variant of the apolipoprotein A-I (apoA-I) gene resulting in FHD. The proband is a 51-year-old woman who was hospitalized due to severe heart failure. Her plasma HDL-cholesterol (C) and apoA-I concentrations were 0.08mmol/l and 1mg/dl, respectively. She exhibited corneal opacities and planar xanthomas on eyelids and elbows. Coronary angiography demonstrated extensive obstructions in two major vessels. Genomic DNA sequencing of the patient's apoA-I gene revealed a homozygosity for a GC deletion between 5 GC repeats in exon 4, creating a frameshift and a stop codon at residue 178. We designated this mutation as apoA-I Shinbashi. The proband's father, son, and daughter were found to be heterozygous for this mutation and their HDL-C and apoA-I levels were about half of normal levels, demonstrating a gene dosage effect. The father underwent coronary bypass surgery at age of 70 years. Lecithin-cholesterol acyltransferase (LCAT) activity was decreased by 63% in the homozygote and 31% in heterozygotes, respectively. This new case of apoA-I deficiency, apoA-I Shinbashi, is the first case involving a single gene defect of the apoA-I gene to develop all the characteristics for apoA-I deficiency, including premature coronary heart disease.
家族性高密度脂蛋白缺乏症(FHD)是一种罕见的常染色体显性脂蛋白紊乱疾病。我们描述了一种导致FHD的载脂蛋白A-I(apoA-I)基因的新型遗传变异。先证者是一名51岁女性,因严重心力衰竭住院。她的血浆高密度脂蛋白胆固醇(C)和apoA-I浓度分别为0.08mmol/l和1mg/dl。她出现角膜混浊以及眼睑和肘部的扁平黄色瘤。冠状动脉造影显示两条主要血管存在广泛阻塞。对患者apoA-I基因进行基因组DNA测序发现,第4外显子中5个GC重复序列之间的GC缺失呈现纯合状态,导致移码并在第178位残基处产生一个终止密码子。我们将此突变命名为apoA-I新桥突变。发现先证者的父亲、儿子和女儿对此突变呈杂合状态,他们的高密度脂蛋白胆固醇(HDL-C)和apoA-I水平约为正常水平的一半,显示出基因剂量效应。父亲在70岁时接受了冠状动脉搭桥手术。纯合子和杂合子的卵磷脂胆固醇酰基转移酶(LCAT)活性分别降低了63%和31%。这种新的apoA-I缺乏症病例,即apoA-I新桥突变,是首例涉及apoA-I基因单基因缺陷并出现包括早发性冠心病在内的所有apoA-I缺乏特征的病例。